Senti Biosciences, Inc. (SNTI)
NASDAQ·Healthcare·Biotechnology
$0.96
-9.45%
Mkt Cap $25.57M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $1.00M | $22.00K | -97.80% | -$0.43 | -$0.38 | +11.63% | — | — |
| Q4 2025 Nov 13, 2025 | $250.00K | — | — | -$0.59 | -$0.69 | -16.95% | — | — |
| Q3 2025 Aug 7, 2025 | $500.00K | — | — | -$0.90 | -$0.56 | +37.78% | — | — |
| Q2 2025 May 6, 2025 | $1.30M | — | — | -$0.58 | -$1.41 | -143.10% | — | — |
| Q1 2025 Mar 20, 2025 | $2.80M | $5.86M | +109.14% | -$3.13 | -$0.67 | +78.59% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | — | -$6.31 | — | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$2.45 | — | — | — |
| Q2 2024 May 9, 2024 | — | — | — | — | -$2.60 | — | — | — |
| Q1 2024 Mar 21, 2024 | $300.00K | $333.00K | +11.00% | -$0.23 | -$4.20 | -1726.09% | — | — |
| Q4 2023 Nov 13, 2023 | $300.00K | $255.00K | -15.00% | -$4.80 | -$2.50 | +47.92% | — | — |
| Q3 2023 Aug 11, 2023 | $500.00K | $937.00K | +87.40% | -$4.80 | -$4.20 | +12.50% | — | — |
| Q2 2023 May 9, 2023 | $500.00K | $1.04M | +107.20% | -$4.80 | -$4.20 | +12.50% | — | — |
| Q1 2023 Mar 22, 2023 | $470.00K | $59.00K | -87.45% | -$4.70 | -$4.20 | +10.64% | — | — |
| Q4 2022 Nov 10, 2022 | $1.54M | $1.77M | +14.68% | -$5.20 | -$3.80 | +26.92% | — | — |
| Q3 2022 Aug 15, 2022 | — | $1.11M | — | — | -$2.65 | — | — | — |
| Q3 2022 Aug 9, 2022 | — | $854.00K | — | — | -$2.70 | — | — | — |
| Q1 2022 Mar 7, 2022 | — | $543.00K | — | — | -$2.50 | — | — | — |
| Q4 2021 Nov 10, 2021 | — | $926.00K | — | — | -$2.61 | — | — | — |
| Q3 2021 Aug 6, 2021 | — | $778.00K | — | — | -$2.75 | — | — | — |
| Q3 2021 Jul 2, 2021 | — | $72.00K | — | — | -$0.00 | — | — | — |